Activation of oncogenes, aberrant metabolism, and defective tumor suppressor genes are intrinsic factors known to promote ROS production in cancer cells, partly through activation of ROS-generating enzymes such as NADPH oxidases [2]. Here, FMO5 is linked to cancer.